133 Results

People

  1. Hudis
    Hudis
  2. Motzer
    Motzer
  3. Gonen
    Gonen
  4. Saltz
    Saltz
  5. Heller
    Heller
  6. Ladanyi
    Ladanyi
  7. Patel
    Patel
  8. Patil
    Patil
  9. Scardino
    Scardino
  10. Shah
    Shah

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (51)
  3. Surgery (37)
  4. Department of Pathology and Laboratory Medicine (27)
  5. Survivorship Research (27)
  6. GSK Faculty (25)
  7. Biostatistics Service (24)
  8. Epidemiology and Biostatistics (24)
  9. Center for Hematologic Malignancies (21)
  10. Center for Pancreatic Cancer Research (21)
  1. "kaplan-meier estimate"
Formats
  1. Journal Article (131)
  2. Editorial (1)
  3. Research Letter (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (51)
  3. Surgery (37)
  4. Department of Pathology and Laboratory Medicine (27)
  5. Survivorship Research (27)
  6. GSK Faculty (25)

More Groups

People
  1. Clifford Hudis (7)
  2. Robert Motzer (7)
  3. Leonard Saltz (5)
  4. Mithat Gonen (5)
  5. Glenn Heller (4)
  6. Jason Huse (4)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (1)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publications
  1. New England Journal of Medicine (21)
  2. Journal of Clinical Oncology (15)
  3. European Urology (6)
  4. JNCI: Journal of the National Cancer Institute (6)
  5. Breast Cancer Research and Treatment (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Massachusetts Medical Society (21)
  2. American Society of Clinical Oncology (15)
  3. Springer (15)
  4. Elsevier Science, Inc. (11)
  5. Elsevier Inc. (10)
  6. Oxford University Press (8)

More Publishers

Results (133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression
    Journal Article

    Mason, W. P.; Belanger, K.; Nicholas, G.; Vallieres, I.; Mathieu, D.; Kavan, P.; Desjardins, A.; Omuro, A.; Reymond, D.
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M. ; Edenfield, W. J.; Wilding, G.; Agarwal, N.; Thompson, J. A.; Cella, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck
    Journal Article

    Prasad, M. L.; Patel, S. G.; Shah, J. P.; Hoshaw-Woodard, S.; Busam, K. J.
    Head and Neck Pathology (2012)

    Fulltext@MSK | Save
  • Factors associated with relapse and survival in Wilms tumor: A multivariate analysis
    Journal Article

    Honeyman, J. N.; Rich, B. S.; McEvoy, M. P.; Knowles, M. A.; Heller, G.; Riachy, E.; Kobos, R.; Shukla, N.; Wolden, S. L.; Steinherz, P. G.; more...
    Journal of Pediatric Surgery (2012)

    Fulltext@MSK | Save
  • Integrative subtype discovery in glioblastoma using iCluster
    Journal Article

    Shen, R.; Mo, Q.; Schultz, N.; Seshan, V. E.; Olshen, A. B.; Huse, J.; Ladanyi, M.; Sander, C.
    PLoS ONE (2012)

    Fulltext@MSK | Save
  • A three-gene expression signature model for risk stratification of patients with neuroblastoma
    Journal Article

    Garcia, I.; Mayol, G.; Rios, J.; Domenech, G.; Cheung, N. K. V.; Oberthuer, A.; Fischer, M.; Maris, J. M.; Brodeur, G. M.; Hero, B.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma
    Journal Article

    Galbán, S.; Lemasson, B.; Williams, T. M.; Li, F.; Heist, K. A.; Johnson, T. D.; Leopold, J. S.; Chenevert, T. L.; Lawrence, T. S.; Rehemtulla, A.; more...
    PLoS ONE (2012)

    Fulltext@MSK | Save
  • Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: An exploratory analysis of the outcomes of elderly patients in the RECORD-1 trial
    Journal Article

    Porta, C.; Calvo, E.; Climent, M. A.; Vaishampayan, U.; Osanto, S.; Ravaud, A.; Bracarda, S.; Hutson, T. E.; Escudier, B.; Grünwald, V.; more...
    European Urology (2012)

    Fulltext@MSK | Save
  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
    Journal Article

    Patel, J. P.; Gonen, M.; Figueroa, M. E.; Fernandez, H.; Sun, Z.; Racevskis, J.; Van Vlierberghe, P.; Dolgalev, I.; Thomas, S.; Aminova, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save